“…That a benzodiazepine antagonist with unquestionably clear actions against benzodiazepine agonists shares anxiolytic actions with a benzodiazepine agonist like diazepam seems paradoxical and uncertainty remains as to how flumazenil exerts these effects (Adinoff et al, 1996;Barnard et al, 1998;Britton et al, 1988;Buck et al, 1991;Criswell and Breese, 1993;Little et al, 1985;Moy et al, 1997Moy et al, , 2000. Discussions have focused on c-aminobutyric acid (GABA)-modulatory neuroactive steroid effects, antagonism of endogenous benzodiazepine receptor inverse agonists (which may vary as a function of chronic ethanol exposure) and differential intrinsic activity at benzodiazepine receptor subtypes (see Barnard et al, 1998 for summary), which are known to change their relative abundance as a function of chronic alcohol exposure (e.g., Cagetti et al, 2003;Devaud et al, 1995;Follesa et al, 2003;Grobin et al, 2000). Although the half-life of flumazenil is exceedingly short (16 minutes, Lister et al, 1984;12 to 20 minutes in human brain, Lassen et al, 1995), its actions appear to far outlast its presence (e.g., Knapp et al, 2005).…”